Literature DB >> 31264961

Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation.

Jamie A Macpherson1,2, Alina Theisen3, Laura Masino4, Louise Fets1, Paul C Driscoll5, Vesela Encheva6, Ambrosius P Snijders6, Stephen R Martin4, Jens Kleinjung7, Perdita E Barran3, Franca Fraternali2, Dimitrios Anastasiou1.   

Abstract

Several enzymes can simultaneously interact with multiple intracellular metabolites, however, how the allosteric effects of distinct ligands are integrated to coordinately control enzymatic activity remains poorly understood. We addressed this question using, as a model system, the glycolytic enzyme pyruvate kinase M2 (PKM2). We show that the PKM2 activator fructose 1,6-bisphosphate (FBP) alone promotes tetramerisation and increases PKM2 activity, but addition of the inhibitor L-phenylalanine (Phe) prevents maximal activation of FBP-bound PKM2 tetramers. We developed a method, AlloHubMat, that uses eigenvalue decomposition of mutual information derived from molecular dynamics trajectories to identify residues that mediate FBP-induced allostery. Experimental mutagenesis of these residues identified PKM2 variants in which activation by FBP remains intact but cannot be attenuated by Phe. Our findings reveal residues involved in FBP-induced allostery that enable the integration of allosteric input from Phe and provide a paradigm for the coordinate regulation of enzymatic activity by simultaneous allosteric inputs.
© 2019, Macpherson et al.

Entities:  

Keywords:  allostery; computational biology; enzymology; molecular biophysics; molecular dynamics; native mass spectrometry; none; structural biology; systems biology

Mesh:

Substances:

Year:  2019        PMID: 31264961      PMCID: PMC6636998          DOI: 10.7554/eLife.45068

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.713


  82 in total

1.  Stimulation of tumor-cell respiration by inhibitors of pyruvate kinase.

Authors:  M Gosalvez; L López-Alarcón; S García-Suarez; A Montalvo; S Weinhouse
Journal:  Eur J Biochem       Date:  1975-06-16

2.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.

Authors:  Berk Hess; Carsten Kutzner; David van der Spoel; Erik Lindahl
Journal:  J Chem Theory Comput       Date:  2008-03       Impact factor: 6.006

3.  Definition and testing of the GROMOS force-field versions 54A7 and 54B7.

Authors:  Nathan Schmid; Andreas P Eichenberger; Alexandra Choutko; Sereina Riniker; Moritz Winger; Alan E Mark; Wilfred F van Gunsteren
Journal:  Eur Biophys J       Date:  2011-04-30       Impact factor: 1.733

Review 4.  Regulation and control of metabolic fluxes in microbes.

Authors:  Luca Gerosa; Uwe Sauer
Journal:  Curr Opin Biotechnol       Date:  2011-05-18       Impact factor: 9.740

5.  Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages.

Authors:  Eva M Palsson-McDermott; Anne M Curtis; Gautam Goel; Mario A R Lauterbach; Frederick J Sheedy; Laura E Gleeson; Mirjam W M van den Bosch; Susan R Quinn; Raquel Domingo-Fernandez; Daniel G W Johnston; Jian-Kang Jiang; Jain-Kang Jiang; William J Israelsen; Joseph Keane; Craig Thomas; Clary Clish; Matthew Vander Heiden; Matthew Vanden Heiden; Ramnik J Xavier; Luke A J O'Neill
Journal:  Cell Metab       Date:  2015-01-06       Impact factor: 27.287

6.  Allosteric regulation of pyruvate kinase M2 isozyme involves a cysteine residue in the intersubunit contact.

Authors:  Y Ikeda; T Noguchi
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

7.  The mechanism of precursor modulation of human pyruvate kinase I by fructose diphosphate.

Authors:  R D Koler; P Vanbellinghen
Journal:  Adv Enzyme Regul       Date:  1968

8.  1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Authors:  Avihai Yacovan; Rachel Ozeri; Tzofit Kehat; Sima Mirilashvili; Daniel Sherman; Alex Aizikovich; Alina Shitrit; Efrat Ben-Zeev; Nili Schutz; Osnat Bohana-Kashtan; Alexander Konson; Vered Behar; Oren M Becker
Journal:  Bioorg Med Chem Lett       Date:  2012-08-23       Impact factor: 2.823

9.  Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.

Authors:  Taro Hitosugi; Sumin Kang; Matthew G Vander Heiden; Tae-Wook Chung; Shannon Elf; Katherine Lythgoe; Shaozhong Dong; Sagar Lonial; Xu Wang; Georgia Z Chen; Jianxin Xie; Ting-Lei Gu; Roberto D Polakiewicz; Johannes L Roesel; Titus J Boggon; Fadlo R Khuri; D Gary Gilliland; Lewis C Cantley; Jonathan Kaufman; Jing Chen
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

10.  Detection of allosteric signal transmission by information-theoretic analysis of protein dynamics.

Authors:  Alessandro Pandini; Arianna Fornili; Franca Fraternali; Jens Kleinjung
Journal:  FASEB J       Date:  2011-11-09       Impact factor: 5.191

View more
  11 in total

1.  Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation.

Authors:  Suparno Nandi; Mortezaali Razzaghi; Dhiraj Srivastava; Mishtu Dey
Journal:  J Biol Chem       Date:  2020-09-28       Impact factor: 5.157

2.  Cancer-associated mutations in human pyruvate kinase M2 impair enzyme activity.

Authors:  Vivian M Liu; Andrea J Howell; Aaron M Hosios; Zhaoqi Li; William J Israelsen; Matthew G Vander Heiden
Journal:  FEBS Lett       Date:  2019-11-16       Impact factor: 4.124

Review 3.  The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.

Authors:  Dexter L Puckett; Mohammed Alquraishi; Winyoo Chowanadisai; Ahmed Bettaieb
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

4.  Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis.

Authors:  Dan He; Huijin Feng; Belen Sundberg; Jiaxing Yang; Justin Powers; Alec H Christian; John E Wilkinson; Cian Monnin; Daina Avizonis; Craig J Thomas; Richard A Friedman; Michael D Kluger; Michael A Hollingsworth; Paul M Grandgenett; Kelsey A Klute; F Dean Toste; Christopher J Chang; Iok In Christine Chio
Journal:  Mol Cell       Date:  2022-06-24       Impact factor: 19.328

5.  Biochemical and structural insights into how amino acids regulate pyruvate kinase muscle isoform 2.

Authors:  Suparno Nandi; Mishtu Dey
Journal:  J Biol Chem       Date:  2020-03-06       Impact factor: 5.157

6.  Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation.

Authors:  Suparno Nandi; Mortezaali Razzaghi; Dhiraj Srivastava; Mishtu Dey
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

7.  Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study.

Authors:  Chara Papadaki; Stavroula Manolakou; Eleni Lagoudaki; Spyros Pontikakis; Despo Ierodiakonou; Konstantinos Vogiatzoglou; Ippokratis Messaritakis; Maria Trypaki; Linda Giannikaki; Maria Sfakianaki; Antonia Kalykaki; Dimitrios Mavroudis; Maria Tzardi; John Souglakos
Journal:  Cancers (Basel)       Date:  2020-04-20       Impact factor: 6.639

8.  A Metabolic Reprogramming Amino Acid Polymer as an Immunosurveillance Activator and Leukemia Targeting Drug Carrier for T-Cell Acute Lymphoblastic Leukemia.

Authors:  Changzheng Li; Xinru You; Xi Xu; Binghuo Wu; Yuye Liu; Tong Tong; Jie Chen; Yishan Li; Chunlei Dai; Zhitao Ye; Xiaobin Tian; Yan Wei; Zechen Hao; Linjia Jiang; Jun Wu; Meng Zhao
Journal:  Adv Sci (Weinh)       Date:  2022-01-26       Impact factor: 16.806

Review 9.  Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents.

Authors:  Bhagyashri Rathod; Shivam Chak; Sagarkumar Patel; Amit Shard
Journal:  RSC Med Chem       Date:  2021-05-17

10.  Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2.

Authors:  Tianshui Sun; Zhuonan Liu; Fangfang Bi; Qing Yang
Journal:  Mol Oncol       Date:  2021-08-25       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.